Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis

Detalhes bibliográficos
Autor(a) principal: Souza, A. R. [UNIFESP]
Data de Publicação: 2000
Outros Autores: Gesztesi, J. L. [UNIFESP], del Negro, GMB, Benard, G., Sato, J. [UNIFESP], Santos, MVB [UNIFESP], Abrahao, T. B. [UNIFESP], Lopes, J. D. [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/26255
http://dx.doi.org/10.1128/CDLI.7.2.175-181.2000
Resumo: Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin America. Patients with PCM show a wide spectrum of clinical and pathological manifestations depending on both host and pathogen factors. Two clinical forms of the disease are recognized: the acute or juvenile form and the chronic or adult form. the major antigenic component of the parasite is a glycoprotein of 43 kDa (gp43). All patient sera present antibodies against gp43 (anti-gp43) and, as demonstrated before by our group, spontaneous anti-idiotypic (anti-Id) antibodies (Ab2) can be detected in patient sera with high titers of anti-gp43. Since it has been postulated that anti-Id antibodies may have a modulating function, we decided to purify and characterize anti-Id antibodies in this system. the possible correlation of Ab2 titers with different clinical forms of disease was also verified. Results showed that purified human anti-Id antibodies (human Ab2) recognized specifically the idiotype of some murine monoclonal anti-gp43 (17c and 3e) but not others (40.d7, 27a, and 8a). Spontaneous anti-Id antibodies were found in all clinical forms of disease. the majority of patients (88%, n = 8) with the acute form of PCM had high titers of Ab2. However, among patients with the multifocal chronic form of the disease, only 29% (n = 14) had high titers of Ab2; 70% (n = 10) of patients with the unifocal chronic form had low titers of Ab2. A correlation between Ab2 titers and anti-gp43 titers was observed before and during antimycotic treatment. Our results suggest that titers of anti-Id antibodies correlate with the severity of PCM in humans.
id UFSP_0ef00023357d22ebf0e14be345835a67
oai_identifier_str oai:repositorio.unifesp.br:11600/26255
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Souza, A. R. [UNIFESP]Gesztesi, J. L. [UNIFESP]del Negro, GMBBenard, G.Sato, J. [UNIFESP]Santos, MVB [UNIFESP]Abrahao, T. B. [UNIFESP]Lopes, J. D. [UNIFESP]Universidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)2016-01-24T12:31:01Z2016-01-24T12:31:01Z2000-03-01Clinical and Diagnostic Laboratory Immunology. Washington: Amer Soc Microbiology, v. 7, n. 2, p. 175-181, 2000.1071-412Xhttp://repositorio.unifesp.br/handle/11600/26255http://dx.doi.org/10.1128/CDLI.7.2.175-181.2000WOS000085699100007.pdf10.1128/CDLI.7.2.175-181.2000WOS:000085699100007Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin America. Patients with PCM show a wide spectrum of clinical and pathological manifestations depending on both host and pathogen factors. Two clinical forms of the disease are recognized: the acute or juvenile form and the chronic or adult form. the major antigenic component of the parasite is a glycoprotein of 43 kDa (gp43). All patient sera present antibodies against gp43 (anti-gp43) and, as demonstrated before by our group, spontaneous anti-idiotypic (anti-Id) antibodies (Ab2) can be detected in patient sera with high titers of anti-gp43. Since it has been postulated that anti-Id antibodies may have a modulating function, we decided to purify and characterize anti-Id antibodies in this system. the possible correlation of Ab2 titers with different clinical forms of disease was also verified. Results showed that purified human anti-Id antibodies (human Ab2) recognized specifically the idiotype of some murine monoclonal anti-gp43 (17c and 3e) but not others (40.d7, 27a, and 8a). Spontaneous anti-Id antibodies were found in all clinical forms of disease. the majority of patients (88%, n = 8) with the acute form of PCM had high titers of Ab2. However, among patients with the multifocal chronic form of the disease, only 29% (n = 14) had high titers of Ab2; 70% (n = 10) of patients with the unifocal chronic form had low titers of Ab2. A correlation between Ab2 titers and anti-gp43 titers was observed before and during antimycotic treatment. Our results suggest that titers of anti-Id antibodies correlate with the severity of PCM in humans.Universidade Federal de São Paulo, Disciplina Imunol, Dept Microbiol Imunol & Parasitol, BR-04023900 São Paulo, BrazilUniv São Paulo, Sch Med, Med Mycol Lab, Inst Med Trop São Paulo, São Paulo, BrazilUniv São Paulo, Sch Med, Lab Med Invest 56, São Paulo, BrazilUniversidade Federal de São Paulo, Disciplina Imunol, Dept Microbiol Imunol & Parasitol, BR-04023900 São Paulo, BrazilWeb of Science175-181engAmer Soc MicrobiologyClinical and Diagnostic Laboratory ImmunologyAnti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALWOS000085699100007.pdfapplication/pdf109000${dspace.ui.url}/bitstream/11600/26255/1/WOS000085699100007.pdf89917529290f3f01015f1a72941865d6MD51open accessTEXTWOS000085699100007.pdf.txtWOS000085699100007.pdf.txtExtracted texttext/plain42085${dspace.ui.url}/bitstream/11600/26255/2/WOS000085699100007.pdf.txt9e288ebb2690a92a0d4676afe74db992MD52open access11600/262552022-09-27 11:18:56.015open accessoai:repositorio.unifesp.br:11600/26255Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:25:10.022545Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
title Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
spellingShingle Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
Souza, A. R. [UNIFESP]
title_short Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
title_full Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
title_fullStr Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
title_full_unstemmed Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
title_sort Anti-idiotypic antibodies in patients with different clinical forms of paracoccidioidomycosis
author Souza, A. R. [UNIFESP]
author_facet Souza, A. R. [UNIFESP]
Gesztesi, J. L. [UNIFESP]
del Negro, GMB
Benard, G.
Sato, J. [UNIFESP]
Santos, MVB [UNIFESP]
Abrahao, T. B. [UNIFESP]
Lopes, J. D. [UNIFESP]
author_role author
author2 Gesztesi, J. L. [UNIFESP]
del Negro, GMB
Benard, G.
Sato, J. [UNIFESP]
Santos, MVB [UNIFESP]
Abrahao, T. B. [UNIFESP]
Lopes, J. D. [UNIFESP]
author2_role author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Souza, A. R. [UNIFESP]
Gesztesi, J. L. [UNIFESP]
del Negro, GMB
Benard, G.
Sato, J. [UNIFESP]
Santos, MVB [UNIFESP]
Abrahao, T. B. [UNIFESP]
Lopes, J. D. [UNIFESP]
description Paracoccidioidomycosis (PCM) is the most prevalent systemic mycosis in Latin America. Patients with PCM show a wide spectrum of clinical and pathological manifestations depending on both host and pathogen factors. Two clinical forms of the disease are recognized: the acute or juvenile form and the chronic or adult form. the major antigenic component of the parasite is a glycoprotein of 43 kDa (gp43). All patient sera present antibodies against gp43 (anti-gp43) and, as demonstrated before by our group, spontaneous anti-idiotypic (anti-Id) antibodies (Ab2) can be detected in patient sera with high titers of anti-gp43. Since it has been postulated that anti-Id antibodies may have a modulating function, we decided to purify and characterize anti-Id antibodies in this system. the possible correlation of Ab2 titers with different clinical forms of disease was also verified. Results showed that purified human anti-Id antibodies (human Ab2) recognized specifically the idiotype of some murine monoclonal anti-gp43 (17c and 3e) but not others (40.d7, 27a, and 8a). Spontaneous anti-Id antibodies were found in all clinical forms of disease. the majority of patients (88%, n = 8) with the acute form of PCM had high titers of Ab2. However, among patients with the multifocal chronic form of the disease, only 29% (n = 14) had high titers of Ab2; 70% (n = 10) of patients with the unifocal chronic form had low titers of Ab2. A correlation between Ab2 titers and anti-gp43 titers was observed before and during antimycotic treatment. Our results suggest that titers of anti-Id antibodies correlate with the severity of PCM in humans.
publishDate 2000
dc.date.issued.fl_str_mv 2000-03-01
dc.date.accessioned.fl_str_mv 2016-01-24T12:31:01Z
dc.date.available.fl_str_mv 2016-01-24T12:31:01Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Clinical and Diagnostic Laboratory Immunology. Washington: Amer Soc Microbiology, v. 7, n. 2, p. 175-181, 2000.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/26255
http://dx.doi.org/10.1128/CDLI.7.2.175-181.2000
dc.identifier.issn.none.fl_str_mv 1071-412X
dc.identifier.file.none.fl_str_mv WOS000085699100007.pdf
dc.identifier.doi.none.fl_str_mv 10.1128/CDLI.7.2.175-181.2000
dc.identifier.wos.none.fl_str_mv WOS:000085699100007
identifier_str_mv Clinical and Diagnostic Laboratory Immunology. Washington: Amer Soc Microbiology, v. 7, n. 2, p. 175-181, 2000.
1071-412X
WOS000085699100007.pdf
10.1128/CDLI.7.2.175-181.2000
WOS:000085699100007
url http://repositorio.unifesp.br/handle/11600/26255
http://dx.doi.org/10.1128/CDLI.7.2.175-181.2000
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Clinical and Diagnostic Laboratory Immunology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 175-181
dc.publisher.none.fl_str_mv Amer Soc Microbiology
publisher.none.fl_str_mv Amer Soc Microbiology
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/26255/1/WOS000085699100007.pdf
${dspace.ui.url}/bitstream/11600/26255/2/WOS000085699100007.pdf.txt
bitstream.checksum.fl_str_mv 89917529290f3f01015f1a72941865d6
9e288ebb2690a92a0d4676afe74db992
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460288092176384